Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
10
2024
Court Dismisses Challenge to Oklahoma’s Meat Labeling Law Keller and Heckman LLP
Jul
9
2024
Health Canada Proposes to Regulate Cloned Animal Products in the Same Manner as Traditional Animal Products Keller and Heckman LLP
Jul
9
2024
FDA Issues Long-Anticipated Draft Guidance on Diversity Action Plans Epstein Becker & Green, P.C.
Jul
9
2024
Recent Federal and State Reproductive Health Developments Greenberg Traurig, LLP
Jul
9
2024
This Week in 340B: July 2 – 8, 2024 McDermott Will & Emery
Jul
9
2024
Two Chinese Food Agencies Release Drafts of New Food Labeling Requirements Keller and Heckman LLP
Jul
8
2024
APHIS Issues Regulatory Status Review Responses Bergeson & Campbell, P.C.
Jul
8
2024
DOJ to Ramp up Antitrust Enforcement in Agriculture Sector Foley & Lardner LLP
Jul
8
2024
Petition for Certiorari Filed in Supreme Court in False Claims Act Case Seeking Review of Whether “Willful” Under the Anti-Kickback Statute Requires Knowledge that the Conduct is Unlawful Mintz
Jul
6
2024
USDA Publishes RFI on the Production of Biofuel Feedstocks Using Climate-Smart Practices Bergeson & Campbell, P.C.
Jul
6
2024
NIOSH Highlights NTRC’s Work on Engineering Controls and PPE Bergeson & Campbell, P.C.
Jul
5
2024
Urinary Catheter Fraud Sparks Proposed Medicare Payment Changes for ACOS K&L Gates
Jul
5
2024
WHALE HUNTING: Temu Facing Another TCPA Class Action After Its Arbitration Clause Deemed Unenforceable Troutman Amin, LLP
Jul
5
2024
Ozempic Lawsuit Overview Oberheiden P.C.
Jul
3
2024
NNI and NNCO Will Hold July 24 Workshop on “Responsible Development, Social Science, and the National Nanotechnology Initiative” Bergeson & Campbell, P.C.
Jul
3
2024
This Week in 340B: June 28 – July 1, 2024 McDermott Will & Emery
Jul
3
2024
Loper Bright Could Shift Outlook for FDA Legal Challenges McDermott Will & Emery
Jul
3
2024
FDA Authorizes First Menthol-Flavored Vapor Products Keller and Heckman LLP
Jul
3
2024
Chobani Petitions FDA to Amend Yogurt Standard of Identity Keller and Heckman LLP
Jul
3
2024
EPA Announces Final Cancellation Order and Updates to Existing Stocks Provisions for Several Chlorpyrifos Products Bergeson & Campbell, P.C.
Jul
2
2024
Federal Circuit Clarifies Rules for Skinny Labelling for Generics and Biosimilar Companies Polsinelli PC
Jul
2
2024
Healthcare Execs Face Federal Drug Charges in Landmark Telehealth Case Bradley Arant Boult Cummings LLP
Jul
2
2024
FDA to Revoke Authorization for Brominated Vegetable Oil in Food Keller and Heckman LLP
Jul
2
2024
Unpacking Averages: Intended Use Words Most Common to Devices That Require Clinical Trials Epstein Becker & Green, P.C.
Jul
1
2024
Ten Things CPG Companies Should Do to Manage Co-Manufacturer Relationships K&L Gates
Jul
1
2024
We Get Work: Life Sciences and Real-World Accommodation Scenarios [Podcast] Jackson Lewis P.C.
Jul
1
2024
It Ain’t Over ‘til It’s Over: IRS Reminds Taxpayers That Section 280E Applies to Marijuana Companies Until Rescheduling Becomes Law Bradley Arant Boult Cummings LLP
Jun
29
2024
Cheers to this! Good News for the North Carolina Alcoholic Beverage Industry Ward and Smith, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins